Integrated Wealth Concepts’s Oragenics OGEN Stock Holding History

Integrated Wealth Concepts’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-45	Closed	-$56K	–	574
2020 Q2	$56K	Buy	+45	New	+$44.3K	﹤0.01%	508

Other funds holding OGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBF

Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Integrated Wealth Concepts's OGEN Position: Q3 2020 in Review

Integrated Wealth Concepts sold out of Oragenics (OGEN) in Q3 2020, closing a stake of 45 shares — an estimated $56K sold.

Integrated Wealth Concepts first reported a position in OGEN in Q2 2020 and held it in 1 quarter. The position peaked at $56K in Q2 2020. 16 funds tracked by Wall St. Rank hold OGEN as of Q3 2020.

Integrated Wealth Concepts reported no remaining Oragenics position as of Q3 2020 after selling out during the quarter.
Integrated Wealth Concepts sold 45 Oragenics shares in Q3 2020, an estimated $56K.
Integrated Wealth Concepts first reported a position in Oragenics in Q2 2020 and held it in 1 quarter.
Integrated Wealth Concepts's Oragenics position peaked at $56K in Q2 2020.
16 funds tracked by Wall St. Rank held Oragenics as of Q3 2020.

Based on Integrated Wealth Concepts's 13F filing for Q3 2020, filed 13 Nov 2020.